Trial Profile
Multi-center, Randomized, Double-blind, Crossover Trial to Evaluate the Pharmacokinetic Comparability of Alpha-1 MP to Prolastin in Subjects With Alpha1-antitrypsin Deficiency.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Mar 2018
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Alpha 1-antitrypsin deficiency
- Focus Pharmacokinetics; Registrational
- Acronyms ChAMP
- Sponsors Grifols
- 14 Apr 2014 New trial record